CD8 alpha

CD8 alpha 詳細

英語名Cluster of differentiation 8市販薬剤の数0
治験薬の数18ターゲットの別称CD8 Antigens
研究&開発段階Phase 3 Clinical
英語名Cluster of differentiation 8
ターゲットの別称CD8 Antigens
市販薬剤の数0
治験薬の数18
研究&開発段階Phase 3 Clinical

CD8 alphaバックグランド

Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. In NK-cells, the presence of CD8A homodimers at the cell surface provides a survival mechanism allowing conjugation and lysis of multiple target cells. CD8A homodimer molecules also promote the survival and differentiation of activated lymphocytes into memory CD8 T-cells.

CD8 alpha分子の別称

CD8A,CD8,Leu2,MAL,p32

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
89Zr-Df-crefmirlimabIAB-22-M2CPhase 3 ClinicalImaginab IncCarcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Melanoma; Multiple Sclerosis; Skin Melanoma; Solid tumours
詳細
RB-0003RB-0003; BNT-111Phase 2 ClinicalBiontech Se, TronMelanoma
詳細
CD8+ memory T cell therapy (Stanford University)Phase 2 ClinicalStanford UniversityLeukemia; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
詳細
GEN-009GEN-009Phase 2 ClinicalGenocea Biosciences IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck
詳細
VE-800VE-800Phase 2 ClinicalVedanta Biosciences IncColorectal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Neoplasm Metastasis; Stomach Neoplasms
詳細
EBViNT Cell (Eutilex)Phase 2 ClinicalEutilexLymphoma, Extranodal NK-T-Cell
詳細
ZED88082AZED88082APhase 2 ClinicalUmcg The University Medical Center GroningenNeoplasm Metastasis; Neoplasms
詳細
AZD-6750AZD6750; AZD-6750Phase 2 ClinicalAstrazeneca PlcCarcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Melanoma; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
詳細
AZD-9793AZD9793; AZD-9793Phase 2 ClinicalAstrazeneca PlcCarcinoma, Hepatocellular; Neoplasm Metastasis; Solid tumours
詳細
AZD-5492AZD5492Phase 2 ClinicalAstrazeneca PlcArthritis, Rheumatoid; Leukemia, B-Cell; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Myositis; Neoplasms
詳細
SNA-00668-Ga-NODAGA-SNA-006; 68Ga-NODAGA-SNA006; SNA-006Phase 2 ClinicalSmartnuclide BiopharmaNeoplasms; Solid tumours
詳細
NY-ESO-1-specific autologous CD8+ T-cell therapy (Fred Hutchinson Cancer Research Center)Phase 1 ClinicalFred Hutchinson Cancer Research Center, National Cancer InstituteLiposarcoma; Sarcoma; Sarcoma, Synovial
詳細
MTX-101 (Mozart Therapeutics)MTX-101 (Mozart Therapeutics)Phase 1 ClinicalMozart Therapeutics IncAutoimmune Diseases; Diabetes Mellitus, Type 1
詳細
[18F]GEH200521GEH200521 (18F); GEH-200521Phase 1 ClinicalGe HealthcareSolid tumours
詳細
Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineGastroesophageal Junction Neoplasms; Stomach Neoplasms
詳細
SCRI-E2CAR_EGFRtv1SCRI-E2CAR_EGFRtv1Phase 1 ClinicalUmoja BioPharma IncOsteosarcoma
詳細
89Zr-DFO-REGN505489Zr-DFO-REGN5054Phase 1 ClinicalRegeneron Pharmaceuticals IncSolid tumours
詳細
AGX-148AGX-148; AGX148Phase 1 ClinicalAgonOx IncColorectal Neoplasms; Genital Neoplasms, Female; Lung Neoplasms; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Urogenital Neoplasms
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8